Polarityte Inc (PTE)

NASDAQ
1.6700
+0.0900(+5.70%)
After Hours
1.6800
+0.0100(+0.5988%)
- Real-time Data
  • Volume:
    229,430
  • Day's Range:
    1.6000 - 1.8500
  • 52 wk Range:
    1.5100 - 27.2500

PTE Overview

Prev. Close
1.58
Day's Range
1.6-1.85
Revenue
5.44M
Open
1.6
52 wk Range
1.51-27.25
EPS
-5.04
Volume
229,430
Market Cap
7.16M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
384,649
P/E Ratio
-
Beta
1.26
1-Year Change
-93.98%
Shares Outstanding
4,290,267
Next Earnings Date
Aug 10, 2022
What is your sentiment on Polarityte?
or
Market is currently closed. Voting is open during market hours.

Polarityte Inc Analysis

Polarityte Inc Company Profile

Polarityte Inc Company Profile

Employees
64

PolarityTE, Inc. is a biotechnology company. The Company is focused on developing regenerative tissue products and biomaterials. It also operates a laboratory testing and clinical research business using equipment, personnel, and facilities it acquired to advance its development of regenerative tissue products. Its first regenerative tissue product is SkinTE, which is intended for the repair, reconstruction, replacement, and supplementation of skin in patients who have a need for treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts. The Company's development projects include SkinTE Cryo, SkinTE point-of-care device, PTE 11000, and others.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellStrong SellSellStrong Sell
Technical IndicatorsStrong SellStrong SellNeutralStrong SellStrong Sell
SummaryStrong SellStrong SellSellStrong SellStrong Sell
  • 1 dollar please
    0
    • go go go
      0
      • Hi are you Enis brother
        0
    • tragic.
      0
      • only tragic
        0
      • holy ********
        0
    • go go go💪💪💪💪
      0
      • Going for $10 by next week !
        1
        • this is huge.buy and hoooold
          1
          • yes 100 son buy and hold
            0
            • Why 100$
              0
            • 100 cent maybe
              0
          • 100 soon
            1
            • Why
              0
          • needs some good news bump .30 at least
            0
            • RTTNews) - PolarityTE, Inc. (PTE) said its Board of Directors has formed a strategic review committee with a view to enhancing shareholder value. The committee will focus on reviewing operational strategies and practices that advance the regulatory process for SkinTE and future financings. The committee also has the authority to review the company's potential strategic opportunities and transactions. Peter Cohen, Chairman of the Board, stated: "The Board believes that, working with the FDA, the pursuit of a BLA for SkinTE is the right path to improving shareholder value in the future."
              2